2023
DOI: 10.1016/j.ijpx.2022.100153
|View full text |Cite
|
Sign up to set email alerts
|

3D printed matrix solid forms: Can the drug solubility and dose customisation affect their controlled release behaviour?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 40 publications
1
3
0
Order By: Relevance
“…The PXRD patterns of HPMC, SD1, and SD2 exhibited no visible diffraction patterns but displayed the characteristic amorphous halo [ 55 , 56 ]. However, the physical mixtures of SD1 and SD2 showed specific peaks at 2θ in the range of 5–20°, indicating a crystalline content from DEX, as previously described in literature [ 52 , 53 ]. In Fig.…”
Section: Resultssupporting
confidence: 80%
See 1 more Smart Citation
“…The PXRD patterns of HPMC, SD1, and SD2 exhibited no visible diffraction patterns but displayed the characteristic amorphous halo [ 55 , 56 ]. However, the physical mixtures of SD1 and SD2 showed specific peaks at 2θ in the range of 5–20°, indicating a crystalline content from DEX, as previously described in literature [ 52 , 53 ]. In Fig.…”
Section: Resultssupporting
confidence: 80%
“…3 C shows the PXRD patterns of HPMC, DEX-SDs, and their corresponding physical mixtures. Because DEX is known to have a crystalline structure [ 52 , 53 ], it is noteworthy that we did not conduct a PXRD study on it. Two characteristic peaks at 8° and 20° on the HPMC diffractogram agree with the previous study [ 54 ].…”
Section: Resultsmentioning
confidence: 99%
“…Contemporary 3D printing technologies provide a versatile platform for preparing highly innovative personalized pharmaceutical dosage forms [26]. Moreover, 3D printing is a valuable technique especially for poorly water-soluble drugs, such as benzodiazepine derivatives, to overcome the challenges related to their formulation, and to enhance their oral bioavailability and therapeutic efficacy [39,40].…”
Section: Discussionmentioning
confidence: 99%
“…Three-dimensional (3D) printing is an emerging manufacturing technology with several applications in the pharmaceutical dosage form design [25]. Modern 3D printing methods enable the preparation of personalized drug delivery systems (DDSs) based on individual patient needs (i.e., specific doses or combinations of drugs) [26]. In addition, 3D printing enables the fabrication of sophisticated DDSs (such as controlled-release and multi-drug preparations) [27], thus improving the therapeutic efficacy of pharmaceuticals and enhancing patient compliance.…”
Section: Semi-solid Extrusion 3d Printing Of Functionalized Polyethyl...mentioning
confidence: 99%